GGrantIndex
← Leaderboards

Mount Sinai School Of Medicine Of Cuny

New York, NY

Compare ↔
$53,958,277
Total funding
207
Grants

Funding mix

By agency

NIH$53,958,277 · 201
AHRQ$0 · 6

By mechanism

P01$28,750,576 · 74
P50$8,437,696 · 20
M01$6,809,564 · 86
P42$3,599,616 · 11
U01$3,549,528 · 9
P30$2,811,297 · 7

Investigators at Mount Sinai School Of Medicine Of Cuny

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

Not enough data

All-Time

Most funded here, all years

1Ze'ev A Ronai$39,572,43717 gr2Susan Morgello$26,508,1177 gr3Joseph D. Buxbaum$22,342,71814 gr4Jonathan D. Licht$17,242,76911 gr5David E. Levy$16,661,2705 gr6Edward H Schuchman$16,357,8826 gr7John H Morrison$15,879,03412 gr8Larry J Siever$13,272,6535 gr

Largest grants

STRUCTURE/FUNCTION OF RECOMBINANT TISSUE FACTOR$364,412
P01 · FY2000 · HL
CORE--PROTEIN PURIFICATION$364,412
P01 · FY2000 · HL
KINETICS OF TISSUE FACTOR PATHWAY$364,412
P01 · FY2000 · HL
TISSUE FACTOR GENE EXPRESSION IN VASCULAR SMOOTH MUSCLE$364,412
P01 · FY2000 · HL
BIOPHYSICS OF TISSUE FACTOR INTERACTIONS$364,412
P01 · FY2000 · HL
ESTROGEN INFLUENCES ON NEUROENDOCRINE AGING$321,210
P01 · FY2000 · AG
CORE--ANIMAL$321,210
P01 · FY2000 · AG
ESTROGEN AND HIPPOCAMPAL CIRCUITRY$321,210
P01 · FY2000 · AG
ESTROGEN REGULATED PLASTICITY OF HIPPOCAMPAL NEURONS$321,210
P01 · FY2000 · AG
ESTROGEN IN CHOLINERGIC BASAL FOREBRAIN AND MESOCORTICAL DOPAMINERGIC SYSTEMS$321,210
P01 · FY2000 · AG
VIRAL PATHOGENESIS OF HIV ASSOCIATED NEPHROPATHY$287,668
P01 · FY2000 · DK
PATHOGENESIS OF HIV ASSOCIATED NEPHROPATHY$287,668
P01 · FY2000 · DK
GENETIC FACTORS FOR PROGRESSION OF HIV ASSOCIATED NEPHROPATHY$287,668
P01 · FY2000 · DK
CORE--CLINICAL AND MOUSE CORE$287,667
P01 · FY2000 · DK
CORE--NEUROPATHOLOGY$248,655
P50 · FY2000 · AG
CORE--CLINICAL RESEARCH SUPPORT$248,655
P50 · FY2000 · AG
RISK FACTORS IN VERY LATE ONSET ALZHEIMERS DISEASE$248,655
P50 · FY2000 · AG
ALPHA 2 AGONIST PLUS A CHOLINESTERASE INHIBITOR IN ALZHEIMERS DISEASE$248,655
P50 · FY2000 · AG
QUANTITATIVE INDICES OF NEURON VULNERABILITY IN DEMENTIA$248,655
P50 · FY2000 · AG
CORE--INFORMATION TRANSFER$248,655
P50 · FY2000 · AG